#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Synovial sarcoma recurrent Polyneuropathy Glomerulonephritis minimal lesion Basal cell naevus syndrome Angiosarcoma non-metastatic Palmar-plantar erythrodysaesthesia syndrome Metastatic malignant melanoma Cystic fibrosis lung Blastic plasmacytoid dendritic cell neoplasia Angiosarcoma recurrent Iron overload Autoimmune disorder Acute graft versus host disease in skin Antiphospholipid antibodies Immune-mediated myositis More trials…

    Learn about Rare Diseases

    Sarcoma – Diagnostics Amyotrophic lateral sclerosis – Treatment Mast cell activation syndrome – Diagnostics Antisynthetase syndrome – Treatment Primary immunodeficiency syndrome Angelman’s syndrome Advanced systemic mastocytosis – Life with Disease IgA nephropathy – Life with Disease Fabry’s disease Turner’s syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Marstacimab Belzupacap Sarotalocan Cibotercept Folic Acid, Anhydrous Pf-07220060 Monohydrate Vepdegestrant Doconexent Imiglucerase ZILEBESIRAN Imiquimod Insulin Aspart Valbenazine Ditosylate Calcium Chloride Dihydrate Teicoplanin F44/10 Iopamidol Datopotamab Deruxtecan Iberdomide Anifrolumab Basiliximab More therapies…

    Learn about Your Condition

    Multiple sclerosis relapse Chondrosarcoma metastatic Mechanical ventilation Pyoderma gangrenosum HIV infection Hypervolaemia Dengue fever HER2 negative breast cancer Ejection fraction normal Femoral hernia Laparotomy Ehlers-Danlos syndrome Elderly Desmoplastic melanoma Femur fracture More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Psoriasis

  • Study to measure bimekizumab concentration in breast milk of breastfeeding mothers with psoriasis, psoriatic arthritis, axial spondyloarthritis, or hidradenitis suppurativa

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    • Bimekizumab
    Germany Spain

  • Study on the Effectiveness and Safety of JNJ-77242113 and Deucravacitinib for Adults with Moderate to Severe Plaque Psoriasis

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Deucravacitinib
    • Jnj-77242113
    Germany Hungary Italy Poland Romania Spain

  • Study on the Effectiveness of JNJ-77242113 and Deucravacitinib for Treating Moderate to Severe Plaque Psoriasis in Adults

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Deucravacitinib
    • Jnj-77242113
    France Germany Hungary Italy Poland Spain

  • ORKA-001 in Patients with Moderate-to-Severe Plaque Psoriasis

    Not recruiting

    2 1
    Investigated Diseases:
    • Psoriasis
    Germany Spain

  • A study to examine how the body processes and removes DC-806 in healthy male volunteers

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • [14C] DC-806
    • Dc-806
    The Netherlands

  • Testing IDOR-1117-2520 for Adults with Moderate to Severe Chronic Plaque Psoriasis With or Without Psoriatic Arthritis

    Not recruiting

    2 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • IDOR-1117-2520C
    Bulgaria Romania
Previous Page
1 2 3 4 5 … 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!